Go Pro

Noble Financial Weighs in on SelectQuote Q1 Earnings

SelectQuote logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Noble Financial maintained a “Strong Buy” rating on SelectQuote and forecast a Q1 2027 loss of $0.26 per share, with estimates ranging from $0.12 EPS in Q2 to a $0.13 loss for FY2028.
  • SelectQuote’s latest quarter fell short of expectations, reporting a $0.19-per-share loss versus the $0.16 consensus estimate and revenue of $321.65 million versus $353.44 million expected.
  • Analyst sentiment is mixed, with MarketBeat showing an average “Hold” rating and a $3.00 price target; the stock opened at $0.54, near its one-year low, while institutional investors own 34.59% of shares.
  • Five stocks to consider instead of SelectQuote.

SelectQuote, Inc. (NYSE:SLQT - Free Report) - Analysts at Noble Financial issued their Q1 2027 EPS estimates for SelectQuote in a research note issued on Wednesday, August 26th. Noble Financial analyst M. Kupinski expects that the company will post earnings of ($0.26) per share for the quarter. Noble Financial has a "Strong-Buy" rating on the stock. The consensus estimate for SelectQuote's current full-year earnings is ($0.11) per share. Noble Financial also issued estimates for SelectQuote's Q2 2027 earnings at $0.12 EPS, Q3 2027 earnings at $0.01 EPS, Q4 2027 earnings at ($0.07) EPS and FY2028 earnings at ($0.13) EPS.

SelectQuote (NYSE:SLQT - Get Free Report) last released its quarterly earnings results on Tuesday, August 25th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.03). The business had revenue of $321.65 million during the quarter, compared to the consensus estimate of $353.44 million. SelectQuote had a return on equity of 19.70% and a net margin of 3.84%.

Other analysts have also issued research reports about the company. Weiss Ratings lowered SelectQuote from a "sell (d+)" rating to a "sell (d)" rating in a report on Monday, August 17th. Zacks Research cut SelectQuote from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, July 1st. One analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $3.00.

Get Our Latest Research Report on SelectQuote

SelectQuote Trading Down 0.8%

NYSE:SLQT opened at $0.54 on Thursday. SelectQuote has a one year low of $0.48 and a one year high of $2.54. The business has a fifty day moving average price of $0.76 and a 200-day moving average price of $0.82. The firm has a market capitalization of $95.93 million, a price-to-earnings ratio of -6.80 and a beta of 1.66. The company has a debt-to-equity ratio of 0.99, a current ratio of 6.57 and a quick ratio of 5.63.

Institutional Investors Weigh In On SelectQuote

Institutional investors and hedge funds have recently modified their holdings of the stock. Hsbc Holdings PLC lifted its holdings in shares of SelectQuote by 850.0% in the second quarter. Hsbc Holdings PLC now owns 122,430 shares of the company's stock worth $102,000 after buying an additional 109,543 shares in the last quarter. Empowered Funds LLC purchased a new position in SelectQuote during the second quarter valued at $245,000. Corient Private Wealth LP bought a new stake in SelectQuote in the 2nd quarter valued at $71,000. Bank of America Corp DE bought a new stake in SelectQuote in the 2nd quarter valued at $328,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in SelectQuote in the 2nd quarter worth $461,000. Institutional investors own 34.59% of the company's stock.

SelectQuote Company Profile

(Get Free Report)

SelectQuote, Inc NYSE: SLQT is a U.S.-based insurance brokerage and lead generation company that connects consumers with a range of insurance products through proprietary technology and licensed agents. The company specializes in life insurance, supplemental health coverage and Medicare plans, leveraging its digital platform and call center operations to help individuals compare policies and find cost-effective solutions tailored to their needs.

Through a single point of contact, policy seekers can evaluate offerings from multiple carriers, including term life, whole life, accidental death, critical illness and long-term care products.

Read More

Earnings History and Estimates for SelectQuote (NYSE:SLQT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in SelectQuote Right Now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines